How India Health 2025 is Catalyzing Equitable and Digital Healthcare

CXOToday has engaged in an exclusive interview with Mr. Yogesh Mudras, Managing Director, Informa Markets in India

1. How do you see India’s healthcare ecosystem evolving, especially in terms of making tech-driven healthcare more accessible?

India’s healthcare ecosystem is undergoing a major transformation, driven by rapid digitisation from telemedicine and AI-powered diagnostics to integrated health records and research and development.

The government’s forward-thinking initiatives in terms of infrastructure development, R &D promotion and regulatory reforms have helped. These have also propelled innovations conceived by budding entrepreneurs of start-ups. However, key challenges remain in such a diverse and populated country like India. For instance, there is a tremendous urban-rural divide, with over 80% of healthcare professionals focusing on cities whereas about 70% of Indians reside in rural areas. Many treatments are considered beyond economic reach while increasingly, Indians are falling prey to non-communicable diseases (NCDs). According to recent studies, one in four Indians is at risk of dying from an NCD before the age of 70. Inadequate and costly care delivery, formalities, and under-regulation often prove to be obstacles where timely treatment is essential. And while helpful initiatives exist, awareness and implementation are not always optimal.

Our mission through the India Health Exhibition 2025, is to create a unified umbrella  of healthcare stakeholders, from innovators, thought leaders, policymakers to hospital administrators and technology providers and the entire ecosystem to address these gaps collaboratively and seeking proactive solutions. By showcasing scalable, tech-enabled trends in areas like diagnostics, hospital infrastructure, and medical devices, and fostering policy dialogue through forums within it, we aim to catalyse real, sustainable change in making high-quality healthcare accessible to every citizen.

2. How is India contributing to the global MedTech dialogue, and what role does India Health 2025 play in this?

India is increasingly seen as a critical player in the global MedTech space, supported by a strong talent base, improved regulatory frameworks, and government initiatives like ‘Make in India’ for medical devices. According to a report by EY, the Indian MedTech market, valued at US$12 billion  in 2024, is projected to reach US$50 billion by 2030, with India’s global market share set to grow from 1.65% to 10%-12% over the next 25 years. The Indian MedTech exports reached US$3.8 billion in last year, with the US as the primary market. Although India remains heavily import-dependent, with strategic growth and innovation, India is well-positioned to strengthen its MedTech industry and reduce import dependency, making significant strides toward becoming a global leader in the sector.

In this context, India Health 2025 plays a pivotal role in advancing this dialogue through dedicated features such as Global Medtech Connect, an international platform where industry leaders, innovators, and regulators can discuss policies, market access, and technology adoption. Our exhibition and conferences will showcase cutting-edge medical technologies and best practices while supporting local manufacturers in scaling and exporting their solutions. By enabling knowledge exchange with global players and encouraging strategic partnerships, we aim to position India as both a major market and a key innovator in shaping the future of healthcare delivery worldwide.

3. What is Informa Markets’ vision for India Health, and how does it align with initiatives like the Digital Health Mission and Make in India?

Our vision for India Health is to be the country’s leading future-ready healthcare platform involves multiple but integrated aspects such as the growth towards equitable, technology-driven, and self-reliant healthcare. There needs to be adherence to regulatory and ethical standards, servicing underserved sectors and continuous improvement in terms of prevention and patient preparedness. We aim to align closely with the National Digital Health Mission by highlighting innovations in electronic health records, telehealth, and AI-powered diagnostics.

Equally, we are deeply committed to supporting the ‘Make in India’ vision by showcasing India’s manufacturing excellence in medical devices, consumables, diagnostics, and hospital infrastructure. In just the second edition, we are bringing together 300+ brands, over 8000 attendees including policymakers, start-ups, and healthcare leaders under one roof, we hope to enable meaningful collaborations that strengthen India’s healthcare ecosystem, promote local innovation, and deliver better patient outcomes. We have onboarded several features such as the India HealthNext Awards, a dual-track conference, match-making app, pavilions to showcase a variety of exciting products which will no doubt be relevant for the industry professionals.

4. How do exhibitions like India Health help drive real-world outcomes in the healthcare sector?

Exhibitions like India Health with the trusted legacy of WHX Dubai, formerly Arab Health   are crucial enablers of sectoral progress. By bringing together over 8,000 stakeholders, India Health 2025 creates a trusted environment for healthcare professionals, manufacturers, investors, and policymakers to share knowledge, explore partnerships, and adopt new technologies that are vital for business opportunities, and fresh innovations.

This translates into real-world outcomes from hospitals sourcing next-generation medical equipment and diagnostics to MedTech innovators securing investment and navigating regulatory pathways. Our event includes features such as the Global Medtech Connect and India Health Leadership Summit, which enable policy dialogue, regulatory alignment, and actionable strategies. Through these initiatives, we’re proud to support an ecosystem that improves patient care, strengthens supply chains, and accelerates India’s journey toward world-class, accessible healthcare.